Acquisitions in Friuli-Venezia Giulia, Italy
Showing 3 transactions.
-
CareHub Acquires 95% of Cormedica S.r.l.December 20, 2024
- Buyer
- CareHub, Brexia Med S.r.l., Silver Economy Fund (Quadrivio Group)
- Target
- Cormedica S.r.l.
- Industry
- Healthcare Services
- Location
- Friuli-Venezia Giulia, Italy
- Type
- Addon
CareHub, a portfolio company of Silver Economy Fund (Quadrivio Group), acquired a 95% stake in Cormedica S.r.l. through its vehicle Brexia Med S.r.l. Cormedica operates multi-specialty outpatient clinics in Italy’s Friuli-Venezia Giulia region, and the deal supports CareHub’s buy-and-build strategy in outpatient diagnostics and local private healthcare.
-
Enovis Corporation Acquires LimaCorporate from EQT Private EquitySeptember 25, 2023
- Buyer
- Enovis Corporation
- Target
- LimaCorporate
- Seller
- EQT Private Equity, Co-shareholders (unspecified)
- Industry
- Medical Devices
- Location
- Friuli-Venezia Giulia, Italy
- Type
- Buyout
Enovis Corporation has agreed to acquire LimaCorporate from EQT Private Equity and its co-shareholders in a strategic combination to create a global orthopaedics leader. LimaCorporate, headquartered in San Daniele del Friuli, Italy, is a specialist orthopaedic implant manufacturer (notably in hip, knee and shoulder systems) that reported EUR 249 million in revenue in 2022 and sells products in 49 countries; the transaction is expected to close in early 2024, subject to customary approvals.
-
Made in Italy Fund (Quadrivio & Pambianco) Acquires Majority Stake in RougjDecember 12, 2019
- Buyer
- Made in Italy Fund (managed by Quadrivio Pambianco), Quadrivio Group, Pambianco
- Target
- Rougj
- Industry
- Consumer Products
- Location
- Friuli-Venezia Giulia, Italy
- Type
- Buyout
Made in Italy Fund, managed by Quadrivio Group and Pambianco, has signed an agreement to acquire a majority stake (reported ~60%) in Rougj, an Italian dermocosmetics company founded in Trieste. The investment aims to create a consolidated group of Italian excellence in the beauty sector and support Rougj’s growth in the pharmacy channel and international markets.